Surrogacy in Brazil: The Legal Framework
The short answer
As of 22 October 2026, the safest short answer is that Brazil’s assisted-reproduction framework contemplates a narrow, non-commercial form of gestational surrogacy under medical-professional rules, but the official materials do not identify a comprehensive federal statute setting out a complete surrogacy code. The central instrument is Federal Council of Medicine (CFM) Resolution No. 2,320/2022. It is a professional ethical standard for physicians, not a statute enacted by Congress. It expressly bars a lucrative or commercial arrangement and sets conditions for assisted-reproduction services. The distinction matters: “commercial surrogacy conflicts with the CFM standard” is supported; “every paid arrangement is automatically a crime or every agreement is void” is not established by that resolution alone. Medical compliance, payment structure, civil remedies, parentage and any criminal-law issue must be assessed separately.
What legislation actually governs the question?
The explanatory note attached to Resolution 2,320/2022 says that, when it was adopted, Brazil had no specific legislation regulating assisted human reproduction. The official legislative records still show proposals rather than an enacted comprehensive code. Chamber of Deputies Bill PL 1,260/2026, which proposes a legal framework for assisted human reproduction, was awaiting designation of a rapporteur in a committee; the latest action listed is 22 April 2026. Senate Bill PL 787/2022 concerns a narrow exceptional situation involving gestational carriers who came to Brazil in the context of the Ukraine–Russia conflict and remained in the legislative process, with the latest listed state on 28 April 2025. A bill does not change current law merely because it has been introduced or reported. The absence of a dedicated statute is not an absence of all applicable law: general family-planning, health, civil-status, child-protection and criminal rules may still matter.
Read each regulatory layer for what it actually does
The instruments have different functions. CFM Resolution 2,320/2022 sets the professional ethical and clinical conditions that physicians must follow when using assisted-reproduction techniques. ANVISA’s RDC 771/2022 concerns sanitary good practices for human germinal cells, germinal tissues and embryos used in assisted reproduction, including inspection of reproduction centres. General legislation may govern family planning, health, civil status, contracts, child welfare or criminal conduct. Civil-registration rules address how a birth is recorded and what documentation a registry office may require. These layers are not interchangeable. A centre’s sanitary compliance does not prove that a particular surrogacy arrangement is ethically compliant; a medical authorization does not conclusively determine contractual enforceability or legal parentage; and a birth-registration route does not legalize every underlying payment arrangement. As of 22 October 2026, the official ANVISA inspection page lists the ART-centre inspection checklist under RDC 771/2022. Law No. 9,263/1996 recognizes access to scientifically accepted conception methods and freedom of choice, but it does not itself establish a detailed surrogacy regime or expressly authorize commercial payment.
When does the CFM framework contemplate surrogacy?
Chapter VII of Resolution 2,320/2022 allows assisted-reproduction clinics, centres or services to use techniques for “gestação de substituição” (gestational surrogacy or temporary uterine transfer) only where a condition prevents or contraindicates pregnancy. This is not framed as a general option chosen solely for convenience. The pathway must also comply with the remaining CFM conditions, including the ban on a lucrative or commercial character. The resolution therefore supports a conditional, medically indicated route, not a general statutory entitlement to commission a pregnancy on any terms. Chapter II’s general provision allowing capable people to receive assisted-reproduction techniques does not remove this specific Chapter VII condition. Chapter VII does not expressly say that being single or being in a same-sex couple, by itself, replaces the stated medical condition. The effect for a particular family configuration should therefore be confirmed with the clinic and, where necessary, the CRM before treatment; do not infer automatic eligibility from general access to assisted reproduction. A clinic should identify the medical indication and applicable requirements before treatment, rather than assume that a signed private agreement is enough.
Carrier conditions and one related limit
Under Chapter VII, the temporary carrier must have at least one living child. As the normal rule, she must belong to the family of one of the partners and be related by blood up to the fourth degree. The resolution illustrates the degrees as parents and children (first), grandparents and siblings (second), aunts/uncles and nieces/nephews (third), and cousins (fourth). If the kinship condition cannot be met, the text says that authorization should be requested from the relevant Regional Council of Medicine (CRM). The resolution’s general exception clause also sends unprovided exceptional cases to the CRM, with an appeal to the Federal Council of Medicine (CFM). These are regulatory approval steps, not automatic waivers. Eligibility details can turn on the exact relationship and facts, so the family tree and any CRM decision should be documented before an embryo transfer is planned.
One related limit is explicit: a woman donating oocytes or embryos cannot also be the temporary carrier under CFM rules. The detailed medical and donor-eligibility requirements are outside this article’s scope.
The express rule on commercial arrangements
Chapter VII, item 2, states that temporary uterine transfer may not have a lucrative or commercial character and that the reproductive clinic may not mediate the selection of the carrier. The prohibition is explicit within the CFM professional framework. A contract cannot, by itself, make a commercial arrangement compliant with a professional rule that bars it. At the same time, the resolution is not a complete statute on the civil or criminal consequences of every payment, intermediary or contract. It is important to state the rule accurately: physicians and reproductive services cannot treat paid, profit-making surrogacy as an ordinary compliant route under this resolution. Whether a particular transfer of money also triggers a separate civil or criminal consequence requires analysis of its purpose, facts and the elements of the relevant law. The resolution does not provide a detailed schedule of permitted reimbursements or an express safe harbour for expenses beyond the required medical care. It is unsafe to assume that a transfer is acceptable merely because it is labelled “reimbursement.” Before payment, record and review its purpose, recipient, supporting evidence, connection to the pregnancy, and any margin or service fee. Changing the label does not change what the arrangement actually pays for. This factual review helps assess CFM compliance but does not by itself establish or exclude a separate offence.
How to classify the proposed arrangement
| Arrangement | What the current framework says | Practical assessment |
|---|---|---|
| Non-commercial gestational surrogacy | A medically indicated arrangement that satisfies the CFM conditions, including carrier eligibility, required records and the non-commercial rule, is the route contemplated by Chapter VII. | Potentially available only if every condition is met; do not treat this as blanket statutory approval. |
| Payment for carrying a pregnancy or a profit-making model | The CFM text expressly says the arrangement cannot have a lucrative or commercial character. | Conflicts with the professional standard. Separate civil or criminal consequences are not automatic and need fact-specific analysis. |
| Medical care and other expense reimbursements | The CFM file must record the intended parents’ commitment to treatment and medical follow-up for the carrier through the postpartum period. The resolution does not provide a complete general schedule or safe harbour for every other reimbursement. | Separate required care from compensation for carrying. Document genuine costs and obtain a written, case-specific assessment before any payment. |
Can a CRM approve an exception?
The resolution expressly contemplates requesting CRM authorization where the normal kinship condition cannot be met, and Chapter IX says exceptional cases not provided for in the resolution depend on authorization by the CRM, with the CFM available at appeal level. This should not be read as an express power to waive every rule. In particular, the text does not state that a CRM may authorize a lucrative or commercial surrogacy arrangement despite the separate no-profit rule. Anyone relying on an alleged exception should obtain the formal written decision and identify exactly which requirement it addresses. A clinic’s informal assurance, a pending application or a previous decision in a different factual setting is not a substitute for approval applicable to the proposed case.
What does a breach mean—and what does it not mean?
Resolution 2,320/2022 describes its annex as a deontological standard to be followed by physicians. Non-compliance may therefore raise professional-disciplinary issues for the doctors involved, depending on the facts and the applicable disciplinary process. The resolution alone does not establish that every person involved has committed a crime, that every payment is trafficking, or that a private agreement is automatically null. Criminal offences have their own statutory elements; civil validity, remedies and damages depend on the applicable law and facts. The reverse overstatement is also unsafe: because there is no comprehensive surrogacy statute, it does not follow that any arrangement or payment is legally safe. Do not rely on generic labels such as “altruistic,” “reimbursement,” “agency fee” or “consulting fee” without examining what the money is actually for and who receives it. Professional discipline under CFM and statutory civil or criminal liability are distinct questions. Any separate offence or remedy must be matched to its own legal elements and the actual facts.
The separate sanitary layer: ANVISA
ANVISA’s RDC 771/2022 governs good practices for human germinal cells, germinal tissues and embryos used in assisted reproduction. ANVISA’s official inspection page lists a specific inspection route for assisted human reproduction centres under that resolution, with an effective date of 20 September 2024. These requirements concern the safety, quality, handling and oversight of biological material and services. They should be checked when selecting or assessing a centre, but they do not replace the CFM’s rule on non-commercial surrogacy and do not decide the enforceability of an agreement with a carrier. Ask the centre to identify its applicable sanitary authorization and current compliance status; do not assume that advertising or a foreign partner’s approval proves compliance in Brazil.
Practical requirements and next steps
The CFM file must include informed consent; a report on the physical and mental health of the people involved; an agreement addressing the child’s legal parentage; the intended parents’ commitment to treatment and follow-up for the carrier through the postpartum period; a commitment to register the birth, with documents arranged during pregnancy; and written spouse/partner approval where the carrier is married or in a stable union. Confirm the current forms with the treating service.
Before treatment, obtain written confirmation of the medical indication, carrier eligibility and kinship or CRM authorization. Have every payment and recipient reviewed for consistency with the non-commercial rule; confirm that the clinic is not mediating carrier selection and check its current ANVISA compliance. Assemble the CFM file before treatment and obtain separate Brazilian-law advice on the agreement and parentage.
If the clinic or CRM refuses the proposed route, request written reasons identifying the exact rule or missing condition. Chapter IX contemplates an appeal to the CFM in exceptional cases; confirm the procedure and deadline from the decision and current council rules. Detailed disputes and remedies require separate advice.
Questions this framework does not decide
Birth registration and legal parentage are separate from compliance with the CFM framework. A registration process does not itself settle contract validity or whether a payment model is commercially prohibited. One specific registry change can be confirmed: CNJ Provision No. 237 of 13 July 2026 amended Article 513(III) of the National Code of Norms so that proof of the intended parents’ marriage or stable union is required only “when there is” such a relationship. This concerns civil-registration documents; it does not relax the CFM medical, kinship or non-commercial conditions, or alter the separate CFM requirement for written approval by the carrier’s spouse or partner where applicable. Confirm the current registration checklist with the civil registry office and Brazilian counsel before relying on it.
Foreign nationality or residence does not create a separate commercial route under the CFM text. Eligibility of foreign intended parents, nationality, travel and recognition of parentage abroad are separate questions requiring advice in the relevant jurisdictions; this article does not decide them.
Bottom line
Brazil’s current framework is best described as a conditional, non-commercial gestational-surrogacy pathway governed chiefly by CFM professional rules, alongside separate sanitary and general legal requirements. The medical indication, carrier conditions, kinship or CRM authorization, absence of a commercial character, clinic’s role and file documents all matter. The CFM resolution is not a comprehensive federal surrogacy statute and does not, by itself, decide criminal liability, contract validity or parentage. Before proceeding, obtain written confirmation of the applicable CFM route, a clear payment-and-expense analysis, current clinic compliance and a separate plan for birth registration and any cross-border recognition.
Sources and legal materials
The legal source text is in Portuguese. The CNJ references below do not establish a complete current registration checklist; confirm the requirements against the full current official texts.
- S1 — CFM Resolution No. 2,320/2022 — full text reproduced by a regional medical council (Portuguese)
- S2 — Law No. 9,263/1996 on family planning — official consolidated text (Portuguese)
- S3 — ANVISA official inspection page for assisted-reproduction centres and RDC 771/2022 (Portuguese)
- S4 — Chamber of Deputies: PL 1,260/2026 status page (Portuguese)
- S5 — Federal Senate: PL 787/2022 status page (Portuguese)
- S6 — CNJ National Code of Norms, current consolidated text (Portuguese)
- S7 — CNJ Provision No. 237/2026 amending Article 513(III) of the National Code (Portuguese)








